SCLERODERMA FAMILY REGISTRY AND DNA REPOSITORY
$658,925N01FY2000ARNIH
Wayne State University, Detroit MI
Investigators
Linked publications & trials
Paper 34738736Paper 32458386Paper 30709959Paper 29732714Paper 29390428Paper 28575534Paper 27111665Paper 26792595Paper 26210123Paper 25578738Paper 25199642Paper 24757152Paper 24387989Paper 23740937Paper 23588945Paper 23444193Paper 23055137Paper 22955019Paper 22896740Paper 22440820Paper 22407130Paper 22402440Paper 22076442Paper 21926187Paper 21779181Paper 21647865Paper 21572159Paper 21429562Paper 21362770Paper 21280007Paper 21223583Paper 21131644Paper 20439528Paper 20391489Paper 20383147Paper 20223638Paper 19950302Paper 19950259Paper 19950257Paper 19933168Paper 19918037Paper 19815934Paper 19799786Paper 19796918Paper 19723904Paper 17530643Paper 17522098Paper 17133608Paper 17075815Paper 16802364Paper 16418202Paper 12905479Paper 12841293
Abstract
The objective of the contract is to characterize the genetic basis for the expression of systemic sclerosis (Ssc). In order to accomplish this, the recurrence rate of Scleroderma within families will be established, a genome wide scan of multicase families will be performed, candidate genes will be identified, and a DNA repository (containing 800 cases and 4,600 unaffected individuals) will be established for use by other investigators. Additionally, lymphocytes from multiplex families will be frozen and stored for later establishment of cell lines to support future research.
View original record on NIH RePORTER →